Endocan reduces the malign grade of gastric cancer cells by regulating associated protein expression
In conclusion, our findings suggest that endocan plays an anti-carcinogenic role in gastric cancer development and progression and might serve as a prognostic biomarker as well as a potential therapeutic target for gastric cancer.
Source: Tumor Biology - Category: Cancer & Oncology Source Type: research
More News: Adenocarcinoma | Biology | Cancer | Cancer & Oncology | Gastric (Stomach) Cancer | Gastroenterology | Genetics | Molecular Biology | Study